Global research trends in signaling pathways of spasmolytic polypeptide-expressing metaplasia pathogenesis: a

Qiumiao Xu1,2, Zhijiang Dai1,2, Chengjin Peng1,2

  • 1Department of Spleen and Stomach, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China.

Frontiers in Oncology
|January 2, 2026
PubMed
Abstract

Insights

This bibliometric analysis maps research on signaling pathways in spasmolytic polypeptide-expressing metaplasia (SPEM) pathogenesis. It identifies key insights and future directions for combating gastric precancerous lesions.

Area of Science:

  • Gastroenterology and Molecular Biology
  • Cancer Research
  • Bibliometric Analysis

Background:

  • Signaling pathways are crucial in spasmolytic polypeptide-expressing metaplasia (SPEM) pathogenesis, especially in gastric cancer precursor lesions.
  • Global research trends in SPEM pathogenesis signaling pathways are not well-defined.
  • This study addresses this gap through bibliometric analysis.

Purpose of the Study:

  • To conduct a comprehensive bibliometric analysis of signaling pathways in SPEM pathogenesis.
  • To map the research field, identify key insights, and guide future research.
  • To inform strategic planning and foster collaboration in SPEM research.

Main Methods:

  • Bibliometric analysis and knowledge mapping using CiteSpace and VOSviewer.
  • Inclusion of articles and reviews from the Web of Science Core Collection.
  • Data analysis of publications, institutions, authors, journals, and countries.

Main Results:

  • 89 papers from 21 countries/regions were analyzed, showing slow publication growth.
  • The United States and China lead in publications; *Gastroenterology* is a leading journal.
  • Research focuses on gene-pathway interplay and cytokines, guiding development of targeted pharmacological agents for gastric precancerous lesions.

Conclusions:

  • This systematic review provides guidance for future research and collaboration in SPEM pathogenesis.
  • There is a need for strengthened interdisciplinary and global partnerships.
  • The findings highlight a shift towards targeted therapies for gastric precancerous lesions.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K